NASDAQ$ACB

Aurora Cannabis Inc · Q1 2026 earnings

Q1 2026 earnings · · Investor relations

Briefing

Aurora Cannabis Q1 FY2026: $98M revenue (+17%), adjusted EBITDA $10.8M

Aurora Cannabis reported first quarter fiscal 2026 (three months ended June 30, 2025) net revenue of $98.0 million, up 17% year over year, driven by 37% growth in medical cannabis to $64.8 million and 74% growth in plant propagation (Bevo) to $23.9 million, partially offset by a 32% decline in consumer cannabis. The company posted a net loss from continuing operations of $19.4 million ($0.26 per share) compared to net income of $3.5 million in the prior-year quarter. Adjusted EBITDA was $10.8 million versus $3.5 million a year ago. Adjusted gross margin on total net revenue was 52%. Free cash flow was $9.2 million. Working capital stood at $308.4 million.

  • Net revenue $98.0M (+17% YoY); medical cannabis $64.8M (+37%) led growth.
  • Adjusted EBITDA $10.8M (+209% YoY) despite net loss of $19.4M from continuing ops.
  • Consumer cannabis revenue declined 32% to $7.9M; plant propagation (Bevo) up 74% to $23.9M.
  • Free cash flow $9.2M; working capital $308.4M.
  • Subsequent EU-GMP certification for Brampton distribution centre to support international medical markets.

Headline financials

Total Revenue

C$71.5M

No prior period
EPS (adj)

-C$0.26

No prior period
Adjusted EBITDA

C$10.8M

No prior period
Adjusted gross margin

52.0%

No prior period
Free cash flow

C$9.23M

No prior period
Capital Expenditures

-C$3.64M

No prior period
Net Income

-C$14.1M

No prior period
Gross Profit

C$20.4M

No prior period
R&D Expense

C$860K

No prior period

Revenue & EPS history

Aurora Cannabis · Revenue · Quarterly

C$71.5M

Q1 2026
Beat estimate in 5 of 13 quarters(38%)
ActualEstimate

Revenue by segment

Aurora Cannabis · C$96.6M total across 3 segments · Q1 2026

  • Medical cannabis
    C$64.8M—
  • Plant propagation (Bevo)
    C$23.9M—
  • Consumer cannabis
    C$7.88M—

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q1 2026

Historical avgQ1 2026

+0.5%

Avg return

Earnings day

+2.9%

Avg return

5 days after

-2.8%

Avg return

30 days after

35%

15 / 43 earnings

Positive

+93.1%

Q3 2020

Best reaction

-34.0%

Q2 2021

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026-5.8%-8.3%—
Q2 2026-4.1%+2.9%+1.3%
Q2 2025-16.7%-21.8%-26.5%
Q4 2023+0.4%+4.3%+27.1%
Q1 2026-11.0%-17.7%+0.5%
Q3 2024+9.6%-1.0%-19.7%
Q2 2024+0.4%-0.6%+10.4%
Q1 2024+0.8%-0.9%+0.2%
Q3 2023-9.2%-7.8%-8.9%
Q2 2023-7.2%-5.4%-24.9%
Q1 2023+26.4%+27.3%-6.6%
Q4 2022-11.6%-18.4%-25.9%
Q3 2022+24.0%+34.9%-38.9%
Q2 2022-3.2%-0.2%-31.7%
Q1 2022-2.7%+16.4%-14.0%
Q4 2021+14.5%+19.0%+15.0%
Q3 2021-11.0%-4.3%+27.4%
Q2 2021-34.0%-25.5%-44.1%
Q1 2021-15.2%-27.7%+0.9%
Q4 2020-18.2%-20.1%-23.3%
Q3 2020+93.1%+152.6%+127.8%
Q2 2020+8.2%+12.3%-47.3%
Q1 2020-23.1%-34.1%-25.9%
Q4 2019-6.2%-13.2%-41.4%
Q3 2019+8.2%+8.2%-5.6%
Q2 2019-5.5%-7.1%+19.5%
Q1 2019-8.1%-12.2%-16.0%
Q4 2018-0.9%+8.8%-15.9%
Q3 2018-0.9%+0.3%+18.2%
Q2 2018+1.3%-0.2%-0.2%
Q1 2018+19.4%+63.6%+79.2%
Q4 2017-2.4%-3.0%-2.6%
Q3 2017+2.2%+1.7%-11.0%
Q2 2017-3.5%-3.5%-2.1%
Q1 2017-1.7%-10.8%-16.5%
Q4 2016+1.8%-2.6%+22.3%
Q3 2016-2.9%——
Q2 2015-0.1%——
Q1 2015+16.0%——
Q4 2015-0.2%——
Q3 2014+0.0%——
Q2 2014+0.0%——
Q1 2014+0.0%——
Q4 2013———
Q3 2013———
Q2 2013———
Q1 2013———
Q4 2012———
Q3 2012———
Q2 2012———
Q1 2012———
Q4 2011———
Q3 2011———
Q2 2011———
Q1 2011———
Q4 2010———
Q3 2010———
Q2 2010———
Q1 2010———
Q4 2009———
Q3 2009———

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro